Peer-reviewedCC BY-NC-ND 4.0JACC: Advances
GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea
- 1Hypertrophic Cardiomyopathy Center, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 2The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio, USA
Related
- Real-World Implementation and Clinical Outcomes of Mavacamten in an Underserved Urban Cohort With Obstructive Hypertrophic Cardiomyopathy
- Liwen Ablation versus Modified Morrow Myectomy for Obstructive Hypertrophic Cardiomyopathy: 1-Year Hemodynamic and Conduction Outcomes
- Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
- Percutaneous endomyocardial ablation as a septal reduction strategy in symptomatic obstructive hypertrophic cardiomyopathy: A 20-year single-center observational experience.
- Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
BibTeX
@article{shah2026glp1,
title = {{GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea}},
author = {Stuti Shah and Mohammed Abusafia and Hesham Sheashaa and Shada Jadam and Susan Ospina and David Kaelber and Susan K. Keen and Milind Y. Desai},
journal = {JACC: Advances},
year = {2026},
month = aug,
doi = {10.1016/j.jacadv.2026.102955},
url = {https://doi.org/10.1016/j.jacadv.2026.102955},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - GLP-1 Receptor Agonist Use and Long-Term Outcomes in Hypertrophic Cardiomyopathy With Obstructive Sleep Apnea
AU - Stuti Shah
AU - Mohammed Abusafia
AU - Hesham Sheashaa
AU - Shada Jadam
AU - Susan Ospina
AU - David Kaelber
AU - Susan K. Keen
AU - Milind Y. Desai
PY - 2026
DA - 2026/08/28
JO - JACC: Advances
DO - 10.1016/j.jacadv.2026.102955
UR - https://doi.org/10.1016/j.jacadv.2026.102955
SN - 2772-963X
ER -